DEA Schedule CII

Strength

2.5; 2.5; 2.5; 2.5 mg/1; mg/1; mg/1; mg/1

Manufacturer

NorthStar Rx LLC

NDC

16714095001

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA202424

On Market Since

3/20/2019

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-2.9%

3M

-5.9%

6M

+1.5%

1Y

-16.7%

3Y

-28.7%

5Y

-14.9%

All

-46.5%